Skip to main content
Clinical Trials/NL-OMON38731
NL-OMON38731
Withdrawn
Phase 2

A feasibility and safety study of bronchoscopic intrabullous autologous blood instillation for the treatment of severe bullous emphysema. - BIABI study

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age \> 35 years
  • \- Large bulla on CT scan were bullectomy is contraindicated or is actively avoided
  • \- Hyperinflation \-\-\> TLC \* 100%predcited and RV \* 150% predicted
  • \- Exertional breathlessness (mMRC \>0\)
  • \- Optimum COPD treatment for at least 6 weeks
  • \- No COPD exacerbation for at least 6 weeks
  • \- Fewer than 3 admissions for infective exacerbations in the preceding 12 months
  • \- Written informed consent
  • \- Patients has stopped smoking for a minimum of 6 months prior to entering the study

Exclusion Criteria

  • \- Inability to obtain informed consent
  • \- Co\-morbidities that would render bronchoscopy or sedation unsafe
  • \- Anaemia or other reasons precluding venesection
  • \- Clinically significant bronchiectasis
  • \- Arrhythmia or cardiovascular disease that poses a risk during procedure
  • \- Lung nodule requiring further investigation or treatment
  • \- Subject taking clopidogrel, warfarin, or other anticoagulants and unable to abstain for 5 days pre\-procedure

Outcomes

Primary Outcomes

Not specified

Similar Trials